` INDOAMIN (Indo Amines Ltd) vs SHW (Sherwin-Williams Co) Comparison - Alpha Spread

INDOAMIN
vs
SHW

Over the past 12 months, INDOAMIN has underperformed SHW, delivering a return of -17% compared to the SHW's +0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
INDOAMIN
SHW
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

INDOAMIN Intrinsic Value
133.39 INR
Undervaluation 15%
Intrinsic Value
Price ₹113.43
SHW Intrinsic Value
260 USD
Overvaluation 22%
Intrinsic Value
Price $335.15
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Indo Amines Ltd
NSE:INDOAMIN
113.43 INR
Sherwin-Williams Co
NYSE:SHW
335.15 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
INDOAMIN, SHW

INDOAMIN
SHW
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Indo Amines Ltd
Revenue
Sherwin-Williams Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
INDOAMIN, SHW

INDOAMIN
SHW
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Indo Amines Ltd
NSE:INDOAMIN
Sherwin-Williams Co
NYSE:SHW
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

INDOAMIN
33.1%
SHW
48.8%

Operating Margin

INDOAMIN
8.3%
SHW
16.1%

Net Margin

INDOAMIN
6.2%
SHW
10.9%

FCF Margin

INDOAMIN
-2.7%
SHW
11.3%

ROE

INDOAMIN
21.4%
SHW
59.4%

ROA

INDOAMIN
8.8%
SHW
10.4%

ROIC

INDOAMIN
10.8%
SHW
13.1%

ROCE

INDOAMIN
22.9%
SHW
21.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
INDOAMIN, SHW

Loading
INDOAMIN
SHW
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
INDOAMIN, SHW

Loading
INDOAMIN
SHW
Difference
www.alphaspread.com

Performance By Year
INDOAMIN, SHW

Loading
INDOAMIN
SHW
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare INDOAMIN to other stocks
4063
Shin-Etsu Chemical Co Ltd
More expensive
vs INDOAMIN
ECL
Ecolab Inc
More expensive
vs INDOAMIN
4957
Yasuhara Chemical Co Ltd
Y
More expensive
vs INDOAMIN
600309
Wanhua Chemical Group Co Ltd
More expensive
vs INDOAMIN
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett